sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology Asia Pacific Immunohistochemistry Market...

2028년까지 아시아 태평양 면역조직화학 시장 예측 – 애플리케이션(진단 및 약물 테스트), 제품(항체, 장비, 시약 및 키트), 최종 사용자(병원 및 진단 실험실, 연구소 및 기타)별 코로나19 영향 및 지역 분석 )

TIPRE00025746 | Pages: 150 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

시장 소개

APAC는 면역조직화학 분야에서 가장 빠르게 성장하는 지역 시장입니다. 중국, 인도, 일본, 한국, 호주 및 기타 APAC 지역이 이 지역 시장의 주요 기여자입니다. 2021년에는 중국이 시장을 주도했습니다. 시장 성장은 R&D 활동 증가, 개발도상국의 의료 부문에 대한 투자 증가, 규제 아웃소싱과 의약품 개발자 간의 협력 증가에 기인합니다. 시장 참여자들이 제품을 출시하고 있습니다. 예를 들어, 2020년 8월 Gilead Sciences Inc.는 중국에서 성인 및 청소년 의약품에 사용하기 위한 HIV 예방제인 Truvada에 대한 승인을 받았습니다. 이 승인은 건강한 인구의 HIV 예방에 도움이 될 것입니다. 아시아 및 태평양 지역에서는 수많은 전염병이 출현, 재출현 또는 재발을 일으키고 있습니다. 더 자주 여행하고, 인구 밀도가 더 높은 지역에 살고, 야생 동물과 더 가깝게 접촉하는 사람들은 새로운 전염병이 빠르게 확산될 가능성을 높였습니다. 현재 코로나19 상황으로 인해 질병 진단을 개선하기 위해 인구 중 인플루엔자 바이러스에 대한 감시가 강화되었습니다. 중국 국가위생건강위원회(NHC)에 따르면 2020년 3월 26일 기준 중국 내 코로나바이러스 감염자는 총 81,285명, 사망자는 3,287명이다. 이 질병은 초기 단계에서 빠른 속도로 전염되었습니다. 그러나 로타바이러스 바이러스, 간염 AE 바이러스, 뎅기열 바이러스 등과 같은 다양한 바이러스 감염으로 인한 질병의 유병률도 예측 기간에 시장을 주도할 것으로 예상됩니다. 이로 인해 전염병의 재발 증가, 진단 역량 개선, 바이러스성 질병에 대한 더 나은 이해에 관한 정부 프로그램의 증가가 향후 몇 년 동안 면역조직화학 시장 성장을 주도할 것으로 예상됩니다. 

APAC 국가, 특히 인도, 코로나19 사태로 인해 많은 영향을 받고 있습니다. 공급망 혼란과 코로나19 치료를 위한 효율적인 치료법에 대한 엄청난 수요로 인해 의료 연구 산업은 APAC에서 중요한 상황에 놓였습니다. 신종 코로나바이러스의 확산을 통제하기 위해 금지 조치가 취해졌습니다. 코로나19 사태는 지역 경제에 부정적인 영향을 미쳤다. 마이너스 인플레이션, GDP 증가, 지역 실업률 급증 등 사회경제적 측면이 심각한 영향을 받았습니다. 중국, 일본, 싱가포르, 한국 등의 국가에서는 임상시험에 대한 관심이 높아지고 있습니다. 서방 국가의 높은 비용도 APAC에 대한 의료 업무 아웃소싱 흐름에 기여하고 있습니다. 아시아 시장으로 판매를 확대하기 위해 제약회사는 약물, 기기, 체외 진단에 대한 새롭고 변화하는 규제 환경을 인식하고 있습니다. GMP 표준, 약품 가격 통제, 의료기기 규제 시스템의 변경을 포함하여 아시아에서는 새로운 규정이나 개선된 규정이 자주 시행됩니다. 현재 표준을 획득하거나 개선하려면 제3자 지침과 조언이 필요합니다. 점점 더 많은 제3자 아웃소싱 서비스 제공업체가 APAC 관련 시장을 지원하는 데 중요한 역할을 하고 있습니다. 그러나 관련 시장의 통제 절차, 국민 인식, 백신 접종 가능성, 정부의 지원 정책 등으로 인해 팬데믹 초기에 비해 시장은 안정됐다.

< u>시장 개요 및 역학

APAC 면역조직화학 시장은 2021년 4억 8,376만 달러에서 2028년까지 8억 1,800만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 7.8%로 성장할 것으로 추정됩니다. 면역조직화학(IHC)은 특정 질병의 항원 분포와 조직 결정을 위한 중요한 응용 단일클론 및 다중클론 항체를 의미합니다. 주로 뎅기열, 간염, 인간면역결핍바이러스(HIV)와 같은 여러 감염성 질환을 탐지하는 데 사용됩니다. 비만, 암, 당뇨병, 심장병 및 뇌졸중과 같은 만성 질환도 이러한 질병의 진단에 도움이 되는 면역조직화학의 주요 응용 분야로 간주됩니다. 당뇨병은 이 지역 전체의 노인 인구에서 높은 비율로 만연하고 있습니다. 당뇨병의 유병률은 과체중과 비만인 사람에게서 더 높습니다. 개발도상국은 물론 선진국에서도 비만율이 급격히 증가하고 있습니다. 건강에 해로운 생활 방식 및 좌식 생활과 같은 요인은 비만인의 수를 증가시키는 주요 요인 중 하나입니다. 심혈관 질환(CVD)에는 뇌혈관 질환, 류마티스성 심장 질환, 관상동맥 심장 질환 및 기타 질환이 포함됩니다. 이는 이 지역 전체에서 질병률과 사망률의 가장 중요한 원인입니다. 또한, 암 발생률과 사망률이 전 지역에서 증가하여 암이 사망 원인의 주요 원인이 되었습니다. 이러한 만성 및 전염병 발병률의 증가는 APAC 지역에서 면역분석 테스트에 대한 수요를 창출할 것으로 예상됩니다.

주요 시장 부문

제품 측면에서 항체 부문은 2020년 APAC 면역조직화학 시장에서 가장 큰 점유율을 차지했습니다. 적용 측면에서 보면 진단 부문은 2020년 APAC 면역조직화학 시장에서 더 큰 시장 점유율을 차지했습니다. 2020년 최종 사용자 기준으로 병원 및 진단 실험실 부문은 APAC 면역조직화학 시장에서 더 큰 점유율을 차지했습니다.  

주요 출처 및 회사 목록

APAC 면역조직화학 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Abcam plc입니다. 애질런트 테크놀로지스, Inc.; 바이오SB; BIO-RAD LABORATORIES INC.; 셀 시그널링 테크놀로지, 인코포레이티드(Cell Signaling Technology, Inc.); 다나허; F. HOFFMANN-LA ROCHE LTD.; 머크 KGaA; 퍼킨엘머 주식회사; 및 THERMO FISHER SCIENTIFIC INC.

보고서 구매 이유

  • APAC 면역조직화학 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별
  • 끊임없이 변화하는 상황을 이해하여 경쟁에서 앞서 나가십시오. APAC 면역조직화학 시장의 경쟁 환경
  • 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 APAC 면역조직화학 시장에서 M&A 및 파트너십 거래를 효율적으로 계획
  • 지각적인 관점에서 지식에 기반한 비즈니스 결정을 내리는 데 도움이 됩니다. APAC 면역조직화학 시장의 다양한 부문 시장 성과에 대한 종합 분석
  • 2021~2028년 APAC 지역의 다양한 부문별 시장 수익 예측을 얻습니다.

 APAC 면역조직화학 시장 세분화

 APAC 면역조직화학 시장 - 제품별

  • 장비
    • 슬라이드 염색 시스템
    • 조직 마이크로어레이 시스템
    • 조직 처리 시스템
    • 슬라이드 스캐너
    • 기타 장비
  • 항체
    • 1차 항체
    • 2차 항체
  • 시약
    • 조직학적 염색
    • 차단 및 고정 시약
    • 발색성 기질
    • 고정 시약
    • 안정제
    • 유기 용매
    • 단백질 분해 효소
    • 희석제
  • 키트

APAC 면역조직화학 시장 - 용도별

  • 진단
    • 암
    • 전염병
    • 자가면역질환
    • 당뇨병
    • 신장 질환
    • 기타
  • 약물 검사

APAC 면역조직화학 시장 - 최종 사용자별

  • 병원 및 진단 실험실
  • 연구소
  • 기타

APAC 면역조직화학 시장 - 국가별

  • 중국  
  • 일본 
  • 인도
  • 호주
  • 대한민국
  • 나머지 APAC

APAC 면역조직화학 시장 - 회사 프로필

  • Abcam plc 
  • Agilent Technologies, Inc.
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Cell Signaling Technology, Inc.
  • 다나허
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA 
  • PerkinElmer Inc.
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        APAC Immunohistochemistry Market – By Product

1.3.2        APAC Immunohistochemistry Market – By Application

1.3.3        APAC Immunohistochemistry Market – By End User

1.3.4        APAC Immunohistochemistry Market – By Country

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             APAC Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       APAC PEST Analysis

4.3       Experts Opinion

5.             APAC Immunohistochemistry Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Escalating Incidences of Chronic and Infectious Diseases

5.1.2        Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Complications Related to Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Burgeoning Opportunities in Emerging Countries

5.4       Future Trends

5.4.1        Growing Acceptance of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – APAC Analysis

6.1       APAC Immunohistochemistry Market Revenue Forecast and Analysis

7.             APAC Immunohistochemistry Market Analysis– By Product

7.1       Overview

7.2       APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3       Antibodies

7.3.1        Overview

7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3        Primary Antibodies

7.3.3.1      Overview

7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4        Secondary Antibodies

7.3.4.1      Overview

7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Equipment Market

7.4.1        Overview

7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        Slide Staining Systems

7.4.3.1      Overview

7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Tissue Microarrays

7.4.4.1      Overview

7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Tissue Processing Systems

7.4.5.1      Overview

7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Slide Scanners

7.4.6.1      Overview

7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Other Equipments

7.4.7.1      Overview

7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Reagents Market

7.5.1        Overview

7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3        Histological Stains

7.5.3.1      Overview

7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4        Blocking Sera & Reagents Market

7.5.4.1      Overview

7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5        Chromogenic Substrates Market

7.5.5.1      Overview

7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6        Stabilizers

7.5.6.1      Overview

7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7        Proteolytic Enzymes

7.5.7.1      Overview

7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8        Organic Solvents

7.5.8.1      Overview

7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9        Fixation Reagents

7.5.9.1      Overview

7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10     Diluents

7.5.10.1    Overview

7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6       Kits Market

7.6.1        Overview

7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8.             APAC Immunohistochemistry Market Analysis – By Application

8.1       Overview

8.2       APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3       Diagnostics

8.3.1        Overview

8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3        Cancer

8.3.3.1      Overview

8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4        Infectious Diseases

8.3.4.1      Overview

8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5        Autoimmune Diseases

8.3.5.1      Overview

8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6        Diabetes Mellitus

8.3.6.1      Overview

8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7        Nephrological Diseases

8.3.7.1      Overview

8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8        Others

8.3.8.1      Overview

8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4       Drug Testing

8.4.1        Overview

8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9.             APAC Immunohistochemistry Market Analysis– By End User

9.1       Overview

9.2       APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3       Hospital & Diagnostic Laboratories

9.3.1        Overview

9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4       Research Institutes

9.4.1        Overview

9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5       Others

9.5.1        Overview

9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.          APAC Immunohistochemistry Market – Country Analysis

10.1    APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1     Overview

10.1.2     APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3    Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2    China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1    China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1        China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3    India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1    India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1        India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6    Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1    Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11.          Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1    APAC: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic developments

12.3.1     Overview

13.          Company Profiles

13.1    Cell Signaling Technology, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    F. HOFFMANN-LA ROCHE LTD.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    MERCK KGaA

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    PerkinElmer Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    THERMO FISHER SCIENTIFIC INC.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Abcam plc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    BIO-RAD LABORATORIES INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Danaher

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Bio SB

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6.             Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9.             China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42.          Organic Developments Done By Companies

Table 43.          Inorganic developments done by Companies

Table 44.          Glossary of Terms

LIST OF FIGURES 

Figure 1.           APAC Immunohistochemistry Market Segmentation

Figure 2.           APAC Immunohistochemistry Market Segmentation, By Country

Figure 3.           APAC Immunohistochemistry Market Overview

Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5.           India to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8.           APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9.           APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10.        APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30.        APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31.        APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32.        APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33.        APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34.        APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35.        APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36.        APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37.        APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38.        APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39.        APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43.        APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44.        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45.        China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46.        India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47.        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48.        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49.        Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Impact of COVID-19 Pandemic in APAC Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC.    
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.    
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription